| MR编号 | NL/H/4002/002 |
|---|
| 药品名称 | Dasatinib Sandoz 50 mg, filmomhulde tabletten |
|---|
| 活性成分 | |
|---|
| 剂型 | Film-coated tablet |
|---|
| 上市许可持有人 | Sandoz B.V.
Hospitaaldreef 29
1315 RC Almere
Nederland |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Dasatinib Sandoz 50 mg, filmomhulde tabletten |
|---|
| 互认成员国 - 产品名称 | - Czechia (CZ)
Dasatinib Sandoz - Denmark (DK)
Dasatinib "Sandoz" - Estonia (EE)
- Norway (NO)
- Germany (DE)
Dasatinib PharOS 50 mg Filmtabletten - Belgium (BE)
Dasatinib Sandoz 50 mg filmomhulde tabletten - United Kingdom (Northern Ireland) (XI)
- France (FR)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Finland (FI)
- Poland (PL)
Dasatinib Sandoz - Latvia (LV)
Dasatinib Sandoz 50 mg apvalkotās tabletes - Lithuania (LT)
Dasatinib Sandoz 50 mg plėvele dengtos tabletės - Hungary (HU)
DASATINIB SANDOZ 50 mg filmtabletta - Bulgaria (BG)
Dasatinib PharOS - Romania (RO)
Dasatinib Sandoz 50 mg comprimate filmate - Slovakia (SK)
Dasatinib PharOS 50 mg - Slovenia (SI)
Dasatinib Sandoz 50 mg filmsko obložene tablete
|
|---|
| 许可日期 | 2018/07/25 |
|---|
| 最近更新日期 | 2025/01/28 |
|---|
| 药物ATC编码 | |
|---|
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Additional Strength/Form
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|